JoVE Logo

Anmelden

5.11 : Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.

The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and aromatic amines. Notable drugs that undergo this process include isoniazid, procainamide, sulfonamides, neurotransmitters like catecholamines, and hormones.

Acetylation has crucial implications for drug toxicity. In certain situations, acetylation can lead to the creation of toxic metabolites. For instance, the acetylation of isoniazid can result in a tissue acylating intermediate that may cause liver toxicity. Furthermore, genetic variations known as acetylation polymorphisms can impact drug metabolism and response. These variations affect the enzymes responsible for acetylation, leading to individuals being either fast or slow acetylators. This distinction results in varied drug efficacy and toxicity levels.

Tags

AcetylationPhase II BiotransformationAcetyltransferase EnzymesDrug MetabolitesAmino GroupSulfonamideHydrazinePrimary AminesSecondary AminesAromatic AminesDrug ToxicityToxic MetabolitesAcetylation PolymorphismsDrug MetabolismFast AcetylatorsSlow Acetylators

Aus Kapitel 5:

article

Now Playing

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

168 Ansichten

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

301 Ansichten

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

226 Ansichten

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

134 Ansichten

article

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

59 Ansichten

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

173 Ansichten

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

68 Ansichten

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

149 Ansichten

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

246 Ansichten

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

154 Ansichten

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

133 Ansichten

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

120 Ansichten

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

35 Ansichten

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

164 Ansichten

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

100 Ansichten

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten